552 related articles for article (PubMed ID: 31827283)
21. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
22. Identification of essential genes for cancer immunotherapy.
Patel SJ; Sanjana NE; Kishton RJ; Eidizadeh A; Vodnala SK; Cam M; Gartner JJ; Jia L; Steinberg SM; Yamamoto TN; Merchant AS; Mehta GU; Chichura A; Shalem O; Tran E; Eil R; Sukumar M; Guijarro EP; Day CP; Robbins P; Feldman S; Merlino G; Zhang F; Restifo NP
Nature; 2017 Aug; 548(7669):537-542. PubMed ID: 28783722
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation.
Teijeira A; Labiano S; Garasa S; Etxeberria I; Santamaría E; Rouzaut A; Enamorado M; Azpilikueta A; Inoges S; Bolaños E; Aznar MA; Sánchez-Paulete AR; Sancho D; Melero I
Cancer Immunol Res; 2018 Jul; 6(7):798-811. PubMed ID: 29678874
[TBL] [Abstract][Full Text] [Related]
24. Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Katkeviciute E; Hering L; Montalban-Arques A; Busenhart P; Schwarzfischer M; Manzini R; Conde J; Atrott K; Lang S; Rogler G; Naschberger E; Schellerer VS; Stürzl M; Rickenbacher A; Turina M; Weber A; Leibl S; Leventhal GE; Levesque M; Boyman O; Scharl M; Spalinger MR
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33001862
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
[TBL] [Abstract][Full Text] [Related]
26. NR4A transcription factors limit CAR T cell function in solid tumours.
Chen J; López-Moyado IF; Seo H; Lio CJ; Hempleman LJ; Sekiya T; Yoshimura A; Scott-Browne JP; Rao A
Nature; 2019 Mar; 567(7749):530-534. PubMed ID: 30814732
[TBL] [Abstract][Full Text] [Related]
27. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Manguso RT; Pope HW; Zimmer MD; Brown FD; Yates KB; Miller BC; Collins NB; Bi K; LaFleur MW; Juneja VR; Weiss SA; Lo J; Fisher DE; Miao D; Van Allen E; Root DE; Sharpe AH; Doench JG; Haining WN
Nature; 2017 Jul; 547(7664):413-418. PubMed ID: 28723893
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
[TBL] [Abstract][Full Text] [Related]
29. PD-1
Donia M; Kjeldsen JW; Andersen R; Westergaard MCW; Bianchi V; Legut M; Attaf M; Szomolay B; Ott S; Dolton G; Lyngaa R; Hadrup SR; Sewell AK; Svane IM
Clin Cancer Res; 2017 Oct; 23(19):5779-5788. PubMed ID: 28679768
[No Abstract] [Full Text] [Related]
30. Deletion of PTPN22 improves effector and memory CD8+ T cell responses to tumors.
Brownlie RJ; Wright D; Zamoyska R; Salmond RJ
JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335326
[TBL] [Abstract][Full Text] [Related]
31. Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8
Gemta LF; Siska PJ; Nelson ME; Gao X; Liu X; Locasale JW; Yagita H; Slingluff CL; Hoehn KL; Rathmell JC; Bullock TNJ
Sci Immunol; 2019 Jan; 4(31):. PubMed ID: 30683669
[TBL] [Abstract][Full Text] [Related]
32. In vivo discovery of immunotherapy targets in the tumour microenvironment.
Zhou P; Shaffer DR; Alvarez Arias DA; Nakazaki Y; Pos W; Torres AJ; Cremasco V; Dougan SK; Cowley GS; Elpek K; Brogdon J; Lamb J; Turley SJ; Ploegh HL; Root DE; Love JC; Dranoff G; Hacohen N; Cantor H; Wucherpfennig KW
Nature; 2014 Feb; 506(7486):52-7. PubMed ID: 24476824
[TBL] [Abstract][Full Text] [Related]
33. Ablation of T cell-associated PD-1H enhances functionality and promotes adoptive immunotherapy.
Hu L; Chen L; Xiao Z; Zheng X; Chen Y; Xian N; Cho C; Luo L; Huang G; Chen L
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34905507
[TBL] [Abstract][Full Text] [Related]
34. Targeting the Tumor Microenvironment of Leukemia and Lymphoma.
Höpken UE; Rehm A
Trends Cancer; 2019 Jun; 5(6):351-364. PubMed ID: 31208697
[TBL] [Abstract][Full Text] [Related]
35. Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.
Chacon JA; Sarnaik AA; Chen JQ; Creasy C; Kale C; Robinson J; Weber J; Hwu P; Pilon-Thomas S; Radvanyi L
Clin Cancer Res; 2015 Feb; 21(3):611-21. PubMed ID: 25472998
[TBL] [Abstract][Full Text] [Related]
36. Adoptive CD8
Jiang X; Xu J; Liu M; Xing H; Wang Z; Huang L; Mellor AL; Wang W; Wu S
Cancer Lett; 2019 Oct; 462():23-32. PubMed ID: 31356845
[TBL] [Abstract][Full Text] [Related]
37. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
38. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.
Zhou J; Shen X; Huang J; Hodes RJ; Rosenberg SA; Robbins PF
J Immunol; 2005 Nov; 175(10):7046-52. PubMed ID: 16272366
[TBL] [Abstract][Full Text] [Related]
39. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
40. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models.
Kagoya Y; Nakatsugawa M; Yamashita Y; Ochi T; Guo T; Anczurowski M; Saso K; Butler MO; Arrowsmith CH; Hirano N
J Clin Invest; 2016 Sep; 126(9):3479-94. PubMed ID: 27548527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
